跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RUZURGI - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RUZURGI
Authorized
STANDARD
RUZURGI
medunik canada
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
109f33076c3bc852
Company
medunik canada
Type
Standard
Approval Details
Approval Id
109f33076c3bc852
Drug Approval Canada Name
RUZURGI
Product Name
RUZURGI
Status
Marketed
Status Date
2023-01-24
Original Market Date
2020-09-24
Din
02503034
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:92.00
Atc Original
N07XX05 AMIFAMPRIDINE
Atc Name
n 07 xx 05
Aig Number
0162417001
Company Name
medunik canada
Company Address
950 Michèle-Bohec Blvd., Blainville, Quebec, Canada, J7C 5E2
Active Ingredients
AMIFAMPRIDINE
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
109f33076c3bc852
Type
Standard
Back to Health Canada Approvals